Abeona Therapeutics Inc.

Direct answer

Abeona Therapeutics Inc. is publicly traded on NASDAQ under the ticker ABEO.

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other...

Can you invest in Abeona Therapeutics Inc.?

Yes. Abeona Therapeutics Inc. is publicly traded on NASDAQ under the ticker ABEO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Abeona Therapeutics Inc.

Detailed equity research is provided by MarketSnap.